Related Experiment Video
Updated: Feb 4, 2026
09:02
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
7.9K
A community- based hepatitis B linkage-to-care program: a case study on Asian Americans chronically infected with
Chul S Hyun1,2, William R Ventura3, Soon S Kim4
11Holy Name Medical Center, Teaneck, NJ USA.
Hepatology, Medicine and Policy
|October 6, 2018
Summary
A patient navigator program effectively linked 42 of 45 individuals with chronic hepatitis B (HBV) to care, overcoming barriers like language and finance. This highlights the program
Area of Science:
- Hepatology and Infectious Diseases
- Public Health and Health Disparities
- Community Health Programs
Background:
- Hepatitis B disproportionately affects Asian Americans, with many remaining unscreened and untreated due to barriers.
- Lack of culturally competent programs hinders linkage to care (LTC) for chronic hepatitis B virus (HBV) infected individuals.
- Personal, socio-cultural, and economic factors present significant obstacles to accessing healthcare for HBV patients.
Purpose of the Study:
- To evaluate barriers affecting LTC in HBV patients.
- To investigate the efficacy of a community-based Patient Navigator (PN) program in expediting LTC.
- To assess the impact of the PN program on health outcomes for HBV patients in a high-risk population.
Main Methods:
- 45 individuals with chronic HBV were identified via community screening and connected with patient navigators (PNs).
- PNs facilitated medical evaluations and follow-up visits, recording patient progress.
- Self-report questionnaires assessed demographics, HBV history, and healthcare access barriers (language, culture, finance).
Main Results:
- 42 out of 45 (93%) HBV-infected individuals were successfully linked to care within 12 months.
- The most significant barriers identified were language and financial constraints, followed by cultural factors.
- 38 individuals were already aware of their HBV infection status from prior screenings.
Conclusions:
- Specific barriers impede access to adequate care for Korean Americans with chronic hepatitis B (CHB).
- Implementing a PN program, integrated with community healthcare networks, can overcome these barriers.
- The PN program shows promise in facilitating LTC and improving health outcomes for HBV patients.
Related Concept Videos
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
280
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
280
01:21Hepatic Portal System
6.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
245
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
245
01:01Phosphodiester Linkages
111.2K
Overview
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
Phosphodiester bond forms when a phosphoric acid molecule (H3PO4) links with two hydroxyl groups (–OH) of two other molecules, forming two ester bonds. Two water molecules are released in this process. The phosphodiester bond is commonly found in nucleic acids (DNA and RNA) and plays a critical role in their structure and function.
Phosphodiester Bonds Link Nucleotides Together
DNA and RNA are polynucleotides or long chains of nucleotides that are linked together. A nucleotide is...
111.2K
00:49Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
01:16Hepatic Drug Excretion: Influencing Factors
589
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
589